Todd Combs is leaving Warren Buffett's Berkshire Hathaway to join JPMorgan

Todd Combs, one of Warren Buffett's two investment deputies and GEICO CEO, has resigned from Berkshire Hathaway to lead JPMorgan's new $10 billion Strategic Investment Group within its Security and Resiliency Initiative. Combs, who joined Berkshire in 2010 to help manage its roughly $300 billion stock portfolio and became GEICO CEO in 2020, is succeeded by GEICO operating chief Nancy Pierce; the moves accompany broader succession planning — Greg Abel set to succeed Buffett, NetJets CEO Adam Johnson shifted to head consumer businesses, Marc Hamburg announcing retirement (June 2027) with Charles Chang named to succeed him in June 2026, and Michael Sullivan joining as general counsel.

Analysis

Market structure: JPMorgan (JPM) is the direct beneficiary — hiring Todd Combs and seeding a $10B Strategic Investment Group signals a meaningful push into private growth and manufacturing equity that will reallocate capital away from public markets and traditional syndicated credit. Berkshire (BRK.B) faces a modest governance/headcount risk as a seasoned portfolio allocator departs, but succession plans reduce systemic disruption; expect a reweighting of Berkshire’s active stock management capacity over 12–24 months. Commodity and industrial suppliers exposed to US manufacturing could see incremental demand over years, while private-equity-like pricing pressure may compress yields in private credit and push public valuations modestly higher in target sectors.

Risk assessment: Tail risks include regulatory backlash (FDIC/FRB scrutiny of bank equity stakes), conflicts of interest, and Combs underperforming in a corporate-investor role — any of which could force asset write-downs >$1B and reputational costs. Immediate market impact (days) should be muted; watch for deal announcements in 3–12 months and JPM filings that could change capital treatment. Hidden dependencies include JPM’s ability to source proprietary, non-dilutive deal flow and the interaction with its trading/prime services balance-sheet usage, which could raise RWAs and pressure ROE if financing becomes large.

Trade implications: Tactical overweight JPM (relative to big-cap banks) and selective long exposure to US industrials/advanced manufacturing supply chains that could receive capital (e.g., industrial metals, tooling, automation). Use option structures to express asymmetric views: buy 9–12 month JPM call spreads while hedging tail risk with cheap OTM puts. Reduce pure-play public private-credit platforms if JPM competes for dealflow and pushes up entry multiples over 6–18 months.

Contrarian angles: The market may underprice JPM’s execution risk and regulatory friction — downside is underappreciated and warrants hedging. Conversely, investors are likely underestimating the potential for superior deal flow and long-term ROIC if Combs replicates Berkshire’s patient capital approach; that would favor a multi-year overweight in JPM and related industrial suppliers. Historical parallels: banks that built merchant-banking arms (Goldman 2000s) delivered variable returns; outcome will be execution- and regulation-dependent.

Key Decisions for Investors

• Establish a 2–3% long position in JPM (ticker JPM) within 30–90 days, targeting +8–12% total return over 12 months if the Strategic Investment Group deploys $5–10B into high-growth/industrial assets; size to portfolio risk and trim to 0.5% if JPM announces material RWA/capital increases.
• Buy a 9–12 month JPM 10–15% OTM call spread (debit) sized to express upside while purchasing a 9–12 month 7–10% OTM put (~0.25 notional of longs) to limit tail loss if regulatory or execution issues materialize.
• Initiate a 1–2% long position in industrial suppliers/equipment makers (domestic industrial mid-caps or ETFs with >30% exposure to manufacturing machinery) to capture potential capital deployments over 12–36 months; target names with gross margins >20% and free-cash-flow yield >5%.
• Avoid new large allocations to public private-credit managers and select PE-lite platforms for 6–18 months as JPM’s capital may bid up entry multiples; if exposure is already present, reduce by 25–40% when JPM announces initial investments.
• Monitor SEC/FRB filings and 8-Ks from JPM and BRK.B over the next 60 days for (a) capital-treatment language, (b) initial deal targets/size, and (c) any regulatory correspondence; if filings show >$2B of disclosed commitments or adverse capital treatment, cut JPM exposure by half within 10 trading days.